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2-3) and Group 2 (SS above or equal to the median and CAC 2-3). After
discharge patients were followed in an outpatients basis, recording major
events and focusing in AAE. Survival-free of AAE curves were calculated
with the Kaplan-Maier method. In order to avoid the potential bias of
confusion variables, we used a multivariate proportional hazards Cox
model, including all variables with a p<0.2 at univariate analysis. Final
resultswerepresentedashazard ratio (HR) forAAEwith its 95%conﬁdence
interval (95% CI).
RESULTS Median follow up was 1.79 years (RIC 0.94-2.86). Median SS
was 14 (RIC 7-23).Clinical variables are listed in Table 1. During follow
up a total of 27 AAE were recorded. Group 0: 8 events (6.6%), Group 1:
9 events (8.5%), and Group 2: 10 events: (23.8%). The Kaplan-Maier
curves are shown in Figure 1. After multivariate Cox analysis, adjusted
HR were the following: HR 4.31 (CI95%: [1.69-11.03], p¼0.002) (com-
parison of group 2 vs. group 0); HR 3.28 (CI95%: [1.28-8.38], p¼0.013)
(group 2 vs. group 1) and HR 1.3 (CI95%: [0.49-3.52], p¼0.013)(group 1
vs. group 0).VariableTotal
population
(N[270)Group 0
(SS<14
and BC 0-1)
122 patientsGroup 1
(SS ‡14
or BC 2-3)
106 patientsGroup 2
(SS ‡14
and BC 2-3)
42 patients p valueAge (yrs) 65.0 (54.0-76.0) 62 (51-73) 66.5 (55-77) 76.5 (65-81) 0.001Men 66.7% 60.7% 76.4% 59.5% 0.44Body mass
index
(kg/m2)27.9 (25.5-30.9) 28.5 (25.8-31.7) 27.7 (25.1-30.2) 27.7 (24.6-
30.1)0.35Diabetes mellitus 20.7% 15.6% 22.6% 31% 0.028Smoker (present
or former)68.9% 70.5% 69.8% 61.9% 0.37Hypertension 70% 59% 79.1% 78.6% 0.002LV ejection
fraction60.0% (50.0-67.0) 60.0% (52.0-70.0) 57.0% (46.0-64) 60% (45-67) 0.017Aspirin 91.1% 95.9% 85.8% 90.5% 0.025Clopidogrel 74.8% 71.3% 79.2% 73.8% 0.38Acenocumarol 5.9% 7.9% 6.6% 7.1% 0.81Statins 93% 91.8% 92.5% 97.6% 0.35b-Blockers 70.7% 68.9% 71.7% 73.8% 0.80STEMI 46.7% 45.1% 56.6% 26.2% 0.03Complete
revascularization70% 81.1% 65.1% 50% 0.001CONCLUSIONS According to our data the combination of SS (14) and
high CAC (2-3) is a strong predictor of AAE, in patients admitted with
an ACS. Further studies are needed to test our results.CATEGORIES CORONARY: Angiography and QCA
KEYWORDS Coronary artery calciﬁcation, Syntax score
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BACKGROUND Coronary artery bypass surgery (CABG) is recom-
mended by guidelines in several scenarios. However, the early oc-
clusion of the grafts is not uncommon. Some clinical factors have been
described as predictors of this early dysfunction but the impact of the
grafted distal vessel on outcomes is poorly understood. We aimed to
develop a new simple angiographic score that would predict patency
problems of the grafts in short- and mid-term.
METHODS We enrolled 249 consecutive patients. All of them under-
went CABG with a mean of 6-year follow-up. “Distal Vessel Quality”
(DVQ) score was calculated by assigning a value from 0 to 9 according
to the criteria of visibility, diameter and size of the distal vessel an-
giographically evaluated. Each variable was quantiﬁed from 0 (worst)
to 3 (best). The mean DVQ score was the result of the cumulative
scores for all distal vessels that were grafted divided by the number of
vessels. Two independent cardiologists, blind to the outcomes,
calculated the DVQ score with low interobserver variability.
RESULTS Mean age was 66.3  9.7 years, 82.7% were males and risk
factors included were: high blood pressure (53.4%), diabetes (30.5%)
and dyslipidemia (49.8%). Each patient received an average of 2.9
grafts until a total of 741, especially to the anterior descending artery
(33%) and obtuse marginal artery (OM) (27%). A total of 453 (61%)
venous grafts and 287 (39%) arterial grafts were implanted. At follow-
up 16% of the patients were admitted due to STEMI (0.4%), non-STEMI
(2%), unstable angina (8.4%) and stable angina (5.2%). Occlusion of 67
grafts was angiographically demonstrated at an average time from
surgery of 511 days (IQR, 168-606), particularly affecting those sutured
to the OM (37%). The occlusion was more often in men (13 vs 3%, p ¼
0.03), venous grafts (11.6 vs 7%, p ¼ 0.01) and patients with lower
single vessel score (5.78  1.01 vs. 6.47  1.36, p ¼ 0.006) and mean
DVQ score (5.86  1.03 vs. 6.32  0.79, p ¼ 0.019). Multivariate analysis
showed that the use of arterial grafts (OR ¼ 0.217, 95% CI [0064-0737],
p ¼ 0.014) and higher values of DVQ score (OR ¼ 0.555, 95% CI [0370-
0832], p ¼ 0.004) were related to longer patency of the grafts.
CONCLUSIONS The DVQ score is a new simple tool to predict out-
comes of coronary artery bypass grafts. Lower values of this score
suggest little beneﬁt of grafting certain vessels. Therefore, this score
could be useful to identify patients who may beneﬁt from percuta-
neous revascularization or hybrid strategies.
CATEGORIES CORONARY: Hybrid Revascularization
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BACKGROUND The difference in prognostic discrimination between
visual assessment of coronary stenosis and quantitative coronary
angiography (QCA) for obstructive disease in patients with suspected
coronary artery disease (CAD) is not known.
METHODS In the PROMISE trial, 10,003 patients with symptoms
suggestive of CAD were randomized to anatomical or functional
testing. Site reports detailing visual stenosis were collected for
B112 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5patients who underwent invasive coronary catheterization. Indepen-
dent, blinded QCA analysis was performed to determine presence of
obstructive disease, deﬁned by 50% stenosis in 1 or more coronary
vessels. The rate of disagreement was determined and cardiovascular
event rates were compared between groups.
RESULTS A total of 929 (9.3%) patients had coronary angiograms with
corresponding site reports; 593 patients had obstructive disease per
site assessment, while 428 had obstructive disease per QCA (Table).
The site read and QCA were different in 177 patients (disagreement
rate 19.1%, simple k¼0.63) of whom 171 had obstructive disease per
site read but not by QCA. One-year event rates were highest (15%)
when QCA and site assessment agreed for obstructive disease,
lowest (2.4%) when QCA and site agreed for no obstructive disease,
and intermediate (7.1%) when disagreement existed between QCA
and site reads (Figure).CAD > 50% 1 Year K-M Event RateQCA + QCA - TOTALS QCA + QCA - TOTALSSite + 422 171 593 15.0% 7.1% 13.2%Site - 6 330 336 NA* 2.4% 2.4%TOTALS 428 501 929 14.8% 4.7% 8.3%*Given the low number of patients with Site – and QCA + (6), no Kaplan-Meier rates were reported or
graphed.CONCLUSIONS Routine visual estimation of angiograms over-
estimates obstructive disease compared to QCA. Site and QCA agree-
ment on CAD >50% or <50% was associated with high and low event
rates, respectively; disagreement was associated with intermediate
rates. These ﬁndings suggest that opportunities exist to improve the
assessment of coronary angiography.
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BACKGROUND The cardiac catheterization laboratory is an important
source of radiation. A reduction in radiation doses as low as possible,maintaining the quality of procedures is essential. Our aim was to
analyze the results of a novel radiation reduction protocol (RRP)
system for coronary angiography and interventional procedures and
the determinants of radiation dose.
METHODS 1130 consecutive procedures from a single catheterization
laboratory [diagnostic coronary angiographies (CA) and percutaneous
coronary interventions (PCI)] were analyzed. 539 were performed
before RRP and 591 after it. RRP implementation consisted in reducing
the number of ventriculographies and aortographies for cases with a
clear indication, reducing number of cine runs, and using as much
as possible low resolution ﬂuoroscopy and last ﬂuoroscopy hold
(a software program that enables dynamic storage of last ﬂuoroscopy
sequences).
RESULTS 69.4% were male with a mean age of 66.8  12.6 years.
There were no signiﬁcant differences in clinical baseline features
nor in the percentage of PCIs performed during the 2 periods
(54.9% vs 52.6%; p¼0.5). They had a similar complexity: syntax
score (18.1  12.2 vs 18.8  14; p¼0.7); acute coronary syndromes
(45.8% vs 44.4%; p¼0.7); bifurcations (26.4% vs 29.8%; p¼0.13)]
apart from a higher proportion of total chronic occlusions per-
formed after the RRP implementation (8.6% vs 13.3%;p¼ 0.01). The
angiographic success was similar in both periods (98.3% vs 99.2%;
p¼ 0.6). After the implementation of RRP, there were no signiﬁcant
differences in median ﬂuoroscopy time (12.7 vs 13.6 min; p¼0.1) and
duration of procedures (25.5 vs 30.4 min; p¼0.14). A signiﬁcant
reduction of the percentage of procedures with ventriculography
(83.6% vs 12.3%; p<0.0001) or aortography (17.7% vs 6.1%;
p<0.0001) was observed, as well as a signiﬁcant reduction in cine
runs (21.1 vs 7.1; p<0.0001) and dose-area product (DAP) (156 vs 71
Gyxcm2; p<0.0001).
CONCLUSIONS With the implementation of a RRP, a highly signiﬁ-
cant 54.5% reduction of DAP was observed without a reduction in the
quality or the complexity of procedures. A RRP should be strongly
considered among interventional cardiology practice.
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BACKGROUND Utilizing lower frame rates (ﬂuoroscopy) is generally
considered to reduce the radiation to the patient. However, there is
little data on the impact of using lower pulse rate (cine) on total ra-
diation dose. In a phantom-model study, we sought to assess the
impact of lower frame/pulse rate and change in intensiﬁer angulation
on radiation dose to the patient.
METHODS A commercially available adult thoracic anthropomorphic
phantom (Lungman, Kyoto Kakagu, Kyoto, Japan) was used to
determine the dose to various organs as shown in Figure 1. Standard
angulations (6 views with 300 and 6 views with 40 0) using cine
acquisitions (10 seconds for each acquisition) and similarly
ﬂuoroscopy using 30 0 angulations (20 seconds for each run) were
chosen to expose the phantom. A sheet (12” x 8”) of radiochromic
dosimetry ﬁlm (Gafchromic XR-QA) was used to determine the
position of maximum skin exposure. Strips (1” x 2”) of radiochromic
ﬁlms attached to phantom at positions 1 to 6 (Figure 1). The
radiochromic strips were changed after every complete cine or
ﬂuoroscopy run (with 6 acquisitions in each run). Dose was estimated
from the radiochromic strips using dose/intensity calibration curves.
Dose-Area product was measured from the X-ray equipment system
(using an in-built ionization chamber placed in the X-ray tube
assembly) for all patients.
